Price $5.83 |
Market Cap
93.5M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.61
|
P/S
2.41
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-1.1K
|
FCF
0.0
|
|
Op. Margin
-15.50%
|
Net Margin
-14.30%
|
ROE
-9.10%
|
ROI
-11.30%
|
|
ROA
-6.10%
|
EPS Growth
28.50%
|
Current Ratio
3.9
|
Debt/Equity
15.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Allergan plc (AGN) | $160.22 | - | 2.20% | 44.79B | Strong Buy |
| InfuSystem Holdings Inc (INFU) | $3.54 | - | - | 66.1M | Strong Buy |
| Integer Holdings Corp (ITGR) | $80.67 | - | - | 2.46B | Strong Buy |
| Bausch Health Companies Inc (BHC) | $23.09 | - | - | 6.58B | Strong Buy |
| Bioanalytical Systems, Inc. (BASI) | $1.42 | - | - | 13.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
